141 related articles for article (PubMed ID: 19456273)
1. Excitatory amino acid transporters as potential drug targets.
Bunch L; Erichsen MN; Jensen AA
Expert Opin Ther Targets; 2009 Jun; 13(6):719-31. PubMed ID: 19456273
[TBL] [Abstract][Full Text] [Related]
2. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.
Bridges RJ; Esslinger CS
Pharmacol Ther; 2005 Sep; 107(3):271-85. PubMed ID: 16112332
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
[TBL] [Abstract][Full Text] [Related]
4. Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human excitatory amino acid transporter subtype 2.
Sagot E; Jensen AA; Pickering DS; Pu X; Umberti M; Stensbøl TB; Nielsen B; Assaf Z; Aboab B; Bolte J; Gefflaut T; Bunch L
J Med Chem; 2008 Jul; 51(14):4085-92. PubMed ID: 18578477
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
Jensen AA; Bräuner-Osborne H
Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
[TBL] [Abstract][Full Text] [Related]
6. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs.
Shigeri Y; Seal RP; Shimamoto K
Brain Res Brain Res Rev; 2004 Jul; 45(3):250-65. PubMed ID: 15210307
[TBL] [Abstract][Full Text] [Related]
7. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
Huerta I; McCullumsmith RE; Haroutunian V; Giménez-Amaya JM; Meador-Woodruff JH
Synapse; 2006 Jun; 59(7):394-402. PubMed ID: 16485262
[TBL] [Abstract][Full Text] [Related]
8. Glutamate-based therapeutic approaches: targeting the glutamate transport system.
Dunlop J
Curr Opin Pharmacol; 2006 Feb; 6(1):103-7. PubMed ID: 16368269
[TBL] [Abstract][Full Text] [Related]
9. Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems.
Shimamoto K
Chem Rec; 2008; 8(3):182-99. PubMed ID: 18563834
[TBL] [Abstract][Full Text] [Related]
10. Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.
Beart PM; O'Shea RD
Br J Pharmacol; 2007 Jan; 150(1):5-17. PubMed ID: 17088867
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional analysis of Na(+)-dependent glutamate transporters from zebrafish brain.
Rico EP; de Oliveira DL; Rosemberg DB; Mussulini BH; Bonan CD; Dias RD; Wofchuk S; Souza DO; Bogo MR
Brain Res Bull; 2010 Mar; 81(4-5):517-23. PubMed ID: 19941938
[TBL] [Abstract][Full Text] [Related]
12. The uncoupled chloride conductance of a bacterial glutamate transporter homolog.
Ryan RM; Mindell JA
Nat Struct Mol Biol; 2007 May; 14(5):365-71. PubMed ID: 17435767
[TBL] [Abstract][Full Text] [Related]
13. Focal reduction of neuronal glutamate transporters in human neocortical epilepsy.
Rakhade SN; Loeb JA
Epilepsia; 2008 Feb; 49(2):226-36. PubMed ID: 17868051
[TBL] [Abstract][Full Text] [Related]
14. Molecular physiology of EAAT anion channels.
Fahlke C; Kortzak D; Machtens JP
Pflugers Arch; 2016 Mar; 468(3):491-502. PubMed ID: 26687113
[TBL] [Abstract][Full Text] [Related]
15. Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities.
Jensen AA; Fahlke C; Bjørn-Yoshimoto WE; Bunch L
Curr Opin Pharmacol; 2015 Feb; 20():116-23. PubMed ID: 25466154
[TBL] [Abstract][Full Text] [Related]
16. Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System.
Malik AR; Willnow TE
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726793
[TBL] [Abstract][Full Text] [Related]
17. Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease.
Zhang Y; Tan F; Xu P; Qu S
Neural Plast; 2016; 2016():8941327. PubMed ID: 26981287
[TBL] [Abstract][Full Text] [Related]
18. Parawixin1: a spider toxin opening new avenues for glutamate transporter pharmacology.
Torres-Salazar D; Fahlke C
Mol Pharmacol; 2007 Nov; 72(5):1100-2. PubMed ID: 17726155
[TBL] [Abstract][Full Text] [Related]
19. Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport.
Nanitsos EK; Nguyen KT; St'astný F; Balcar VJ
J Biomed Sci; 2005 Dec; 12(6):975-84. PubMed ID: 16228297
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of anion conduction by coupled glutamate transporters.
Machtens JP; Kortzak D; Lansche C; Leinenweber A; Kilian P; Begemann B; Zachariae U; Ewers D; de Groot BL; Briones R; Fahlke C
Cell; 2015 Jan; 160(3):542-53. PubMed ID: 25635461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
